Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2018 | 04-2018 | 01-2018 | 10-2017 | 07-2017 | |
| Sales | 363 | 750 | 0 | 0 | 363 |
| Gross Profit | 363 | 750 | N/A | N/A | 363 |
| Operating Expenses | 5,968 | 2,151 | 1,875 | 1,738 | 2,093 |
| Operating Income | -5,606 | -1,401 | -1,875 | -1,738 | -1,731 |
| Interest Expense | 0 | 0 | 0 | 58 | 72 |
| Other Income | 12 | 9 | 9 | 10 | 8 |
| Pre-tax Income | -5,594 | -1,393 | -1,866 | -1,786 | -1,794 |
| Net Income Continuous | -5,594 | -1,393 | -1,866 | -1,786 | -1,794 |
| Minority Interests | -117 | -14 | -27 | N/A | N/A |
| Net Income | $-5,477 | $-1,379 | $-1,838 | $-1,786 | $-1,794 |
| EPS Basic Total Ops | -0.30 | -0.08 | -0.11 | -0.07 | -0.12 |
| EPS Basic Continuous Ops | -0.30 | -0.08 | -0.11 | -0.12 | -0.12 |
| EPS Diluted Total Ops | -0.30 | -0.08 | -0.11 | -0.07 | -0.12 |
| EPS Diluted Continuous Ops | -0.30 | -0.08 | -0.11 | -0.12 | -0.12 |
| EBITDA(a) | $-5,519 | $-1,317 | $-1,789 | $-1,873 | $-1,639 |